rs6435639

Variant names:

• chr2-211538598-G-A
• rs6435639
• NM_005235.3:c.2487+23305C>T

Your query was ambiguous. Multiple possible variants found:

• chr2-211538598-G-A
• chr2-211538598-G-C
• chr2-211538598-G-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_Strong BA1

The NM_005235.3(ERBB4):​c.2487+23305C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.727 in 151,634 control chromosomes in the GnomAD database, including 41,233 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

• Frequency: Genomes: 𝑓 0.73 (41233 hom., cov: 31)
• Consequence: ERBB4 NM_005235.3 intron
• Clinical Significance: Not reported in ClinVar
• Conservation: PhyloP100: -0.121
• Publications: 3 publications found

Genes affected

ERBB4 (HGNC:3432): (erb-b2 receptor tyrosine kinase 4) This gene is a member of the Tyr protein kinase family and the epidermal growth factor receptor subfamily. It encodes a single-pass type I membrane protein with multiple cysteine rich domains, a transmembrane domain, a tyrosine kinase domain, a phosphotidylinositol-3 kinase binding site and a PDZ domain binding motif. The protein binds to and is activated by neuregulins and other factors and induces a variety of cellular responses including mitogenesis and differentiation. Multiple proteolytic events allow for the release of a cytoplasmic fragment and an extracellular fragment. Mutations in this gene have been associated with cancer. Alternatively spliced variants which encode different protein isoforms have been described; however, not all variants have been fully characterized. [provided by RefSeq, Jul 2008]

ERBB4 Gene-Disease associations (from GenCC):

• amyotrophic lateral sclerosis type 19

  Inheritance: AD Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics, Genomics England PanelApp
• amyotrophic lateral sclerosis

  Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

ACMG classification

Our verdict: Benign. The variant received -12 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.99).
• BA1: GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.91 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005235.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	ERBB4	NM_005235.3	MANE Select	c.2487+23305C>T		intron	N/A	NP_005226.1	Q15303-1
	ERBB4	NM_001439005.1		c.2457+23305C>T		intron	N/A	NP_001425934.1
	ERBB4	NM_001042599.2		c.2487+23305C>T		intron	N/A	NP_001036064.1

Ensembl Transcripts

Sel.	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	ERBB4	ENST00000342788.9	TSL:1 MANE Select	c.2487+23305C>T		intron	N/A	ENSP00000342235.4	Q15303-1
	ERBB4	ENST00000436443.5	TSL:1	c.2487+23305C>T		intron	N/A	ENSP00000403204.1	Q15303-3
	ERBB4	ENST00000260943.11	TSL:5	c.2457+23305C>T		intron	N/A	ENSP00000260943.7	Q15303-4

Frequencies

GnomAD3 genomes AF: 0.726 AC: 110046 AN: 151516 Hom.: 41171 Cov.: 31

Gnomad AFR AF: 0.917

Gnomad AMI AF: 0.693

Gnomad AMR AF: 0.689

Gnomad ASJ AF: 0.656

Gnomad EAS AF: 0.795

Gnomad SAS AF: 0.697

Gnomad FIN AF: 0.619

Gnomad MID AF: 0.611

Gnomad NFE AF: 0.637

Gnomad OTH AF: 0.710

We have no GnomAD4 exomes data on this position. Probably position not covered by the project.

GnomAD4 genome AF: 0.727 AC: 110169 AN: 151634 Hom.: 41233 Cov.: 31 AF XY: 0.723 AC XY: 53571 AN XY: 74072

African (AFR) AF: 0.917 AC: 38065 AN: 41492

American (AMR) AF: 0.689 AC: 10474 AN: 15198

Ashkenazi Jewish (ASJ) AF: 0.656 AC: 2271 AN: 3462

East Asian (EAS) AF: 0.795 AC: 4092 AN: 5148

South Asian (SAS) AF: 0.696 AC: 3350 AN: 4812

European-Finnish (FIN) AF: 0.619 AC: 6497 AN: 10488

Middle Eastern (MID) AF: 0.605 AC: 178 AN: 294

European-Non Finnish (NFE) AF: 0.637 AC: 43108 AN: 67720

Other (OTH) AF: 0.713 AC: 1502 AN: 2108

Alfa AF: 0.673 Hom.: 7069

Bravo AF: 0.740

Asia WGS AF: 0.798 AC: 2776 AN: 3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.99
CADD	Benign	1.1
DANN	Benign	0.48
PhyloP100		-0.12
Mutation Taster		=100/0	polymorphism (auto)

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Other links and lift over

dbSNP: rs6435639;

hg19: chr2-212403323;